Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities BARCHEL D., STOLAR O., De-HAAN T., ZIV-BARAN T., SABAN N., FUCHS D.O., KOREN G., BERKOVITCH M. Frontiers in Pharmacology, 2019, 9, 1521. doi : 10.3389/fphar.2018.01521, PMID : 30687090 Objective: Children with autism spectrum disorder (ASD) commonly exhibit comorbid symptoms such as aggression, hyperactivity and anxiety. Several studies are being conducted worldwide on cannabidiol use in ASD; however, these studies are still ongoing, and data on the effects of its use is very limited. In this study we aimed to report the experience of parents who administer, under supervision, oral [...]
Lire la suiteBibliographie Cannabinoïdes et Epilepsie Docteur Christian SUEUR, GRECC, septembre 2018. AGUIRRE-VELASQUEZ C.G. : Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with refractory Epilepsy, Hindawi, Neurology Research International, 2017, ID 2985729, 5 p. American Academy of Neurology : Medical marijuana liquid extract may bring hope for children with severe epilepsy, American Academy of Neurology Press, 2015. https://www.aan.com/PressRoom/Home/PressRelease/1364 AMES F.R., CRIDLAND S. : Anticonvulsivant effect of cannabidiol, South Africa Medical Journal, 1986, 69, 1, 14. ANDERSON P. : Positive Topline Results with Cannabidiol (Epidiolex) in Dravet Syndrome, medscape.com/viewarticle/860357_print, 2016 BLAIR R.E., DESHPANDE L.S., De LORENZO R.J. : Cannabinoids : is there [...]
Lire la suite